Jan 8, 2018
Natalie Porat-Shliom, Ph.D. has joined the Thoracic and Gastrointestinal Oncology Branch (TGIB) as a Stadtman Tenure Track Investigator. Dr. Porat-Shliom's research focuses on utilizing intravital microscopy for imaging and understanding the biology of human cancer. She will explore how normal and malignant cells metabolically adapt to changes in nutrient supply and energy demand and will address specific questions concerning metabolic heterogeneity under physiological conditions and metastatic disease using both mouse model and human samples. Learn more...
Dec 13, 2017
Thomas A. Waldmann, M.D., Co-chief of the Lymphoid Malignancies Branch, has been named a Fellow of the National Academy of Inventors (NAI). According to the NAI, election to NAI fellow status is the highest professional accolade for academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society. With the election of the 2017 class there are now 912 NAI Fellows, representing over 250 research universities and governmental and non-profit research institutes. On April 5, 2018, the 2017 NAI Fellows will be inducted as part of the Seventh Annual NAI Conference.
Dec 12, 2017
Anupama Khare, Ph.D. has joined the Laboratory of Molecular Biology as a Stadtman Tenure Track Investigator. Dr. Khare's research focuses on understanding how different microbial species co-exist in the same environmental niche and what the molecular interactions in such communities are. She is also interested in studying antibiotic persistence and identifying novel bacterial pathways that can be targeted for antimicrobial therapy in investigating the genetic basis of complex bacterial behaviors in natural environments, with an overarching goal of identifying novel targets for antibiotic therapies. Learn more...
Nov 27, 2017
Claudia Palena, Ph.D., has been appointed as a tenured senior investigator in the Laboratory of Tumor Immunology and Biology (LTIB). Dr. Palena’s laboratory focuses on the immunological targeting of drivers of tumor dissemination and resistance to therapy. Her recent work identified the novel tumor antigen brachyury as a key factor in epithelial to mesenchymal transition (EMT), a process associated with cancer progression. More recently, Dr. Palena’s efforts have been aimed at investigating immunotherapeutic approaches that may be used alone or in combination with anti-neoplastic agents to disrupt tumor metastasis and resistance to therapy.
Nov 27, 2017
Stephanie Goff, M.D., Staff Clinician in the Surgery Branch, was among 1,827 initiates from around the world who became Fellows of the American College of Surgeons (FACS) during the convocation ceremony at the college’s annual Clinical Congress on Oct. 22, 2017. According to the college, Fellows have earned the distinguished right to use the designation of “FACS” (Fellow, American College of Surgeons) after their names. Fellowship requirements include completion of advanced training in one of 14 surgical specialties, certification by an American surgical specialty board or appropriate certification by the Royal College of Physicians and Surgeons of Canada and demonstrating ethical fitness and professional proficiency. The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and to improve the quality of care for the surgical patient.
Nov 13, 2017
Haneen Shalabi, D.O., a Physician in the Pediatric Oncology Branch, received the 2017 Next Gen Award from the Children’s Cancer Foundation, Inc (CCF). As the highest award CCF presents to individual researchers, the Next Gen Award recognizes young investigators who are committed to pursuing a long-term career in pediatric oncology research. Read more...
Nov 13, 2017
Many cancer experts predict the newest innovation in cancer treatment will be the development of blood tests, called liquid or blood biopsies, that can monitor the growth of tumors by analyzing DNA shed from tumors into the bloodstream. A recent article from Axios highlights NCI’s initiative to support the development and validation of these tests through a partnership with engineers and clinical experts. Mark Roschewski, M.D., Staff Clinician in the Lymphoid Malignancies Branch, notes there is little doubt these tests will be available soon and says the “only question is when and at what breadth.” Read the full story…
Oct 17, 2017
Shiv Grewal, Ph.D., Chief of the Laboratory of Biochemistry and Molecular Biology, has been named an Indian National Science Academy (INSA) Foreign Fellow for his pioneering contributions on the role of epigenetic modifications in heterochromatin assembly and discovery of relation between heterochromatin assembly and RNAi. The INSA Foreign Fellowship is designated to scientists recognized as international leaders in their field. Dr. Grewal is one of four researchers to receive the 2017 fellowship.
Oct 11, 2017
Vassiliki Saloura, M.D., has joined the Thoracic and Gastrointestinal Oncology Branch (TGIB) as an Assistant Clinical Investigator. Dr. Saloura’s laboratory investigates the role of histone and non-histone protein methylation in tumor growth, therapy resistance and immunogenicity in squamous cell carcinoma of the aerodigestive tract. Learn more . . .
Oct 2, 2017
H. Efsun Arda, Ph.D., has joined the Laboratory of Receptor Biology and Gene Expression (LRBGE) as a Stadtman tenure track investigator. Dr. Arda spearheaded the development of genomic and epigenetic analysis of primary pancreatic cells obtained from children and adult donors using single cell analysis. Her research focuses on understanding the genomic information that governs development, differentiation and function of pancreatic cell lineages. Learn more...